Tzvi Palash

2014

In 2014, Tzvi Palash earned a total compensation of $482.8K as Chief Operating Officer at Protalix BioTherapeutics, a 20% decrease compared to previous year.

Compensation breakdown

Bonus$50,000
Option Awards$11,413
Salary$233,669
Stock Awards$113,161
Other$74,520
Total$482,763

Palash received $233.7K in salary, accounting for 48% of the total pay in 2014.

Palash also received $50K in bonus, $11.4K in option awards, $113.2K in stock awards and $74.5K in other compensation.

Rankings

In 2014, Tzvi Palash's compensation ranked 10,384th out of 13,032 executives tracked by ExecPay. In other words, Palash earned more than 20.3% of executives.

ClassificationRankingPercentile
All
10,384
out of 13,032
20th
Division
Manufacturing
3,945
out of 4,965
21st
Major group
Chemicals And Allied Products
1,359
out of 1,690
20th
Industry group
Drugs
1,089
out of 1,369
21st
Industry
Biological Products, Except Diagnostic Substances
197
out of 241
18th
Source: SEC filing on March 16, 2017.

Palash's colleagues

We found four more compensation records of executives who worked with Tzvi Palash at Protalix BioTherapeutics in 2014.

2014

Yossi Maimon

Protalix BioTherapeutics

Chief Financial Officer

2014

Yoseph Shaaltiel

Protalix BioTherapeutics

Executive Vice President, Research and Development

2014

Einat Almon

Protalix BioTherapeutics

Senior Vice President, Product Development

2014

Moshe Manor

Protalix BioTherapeutics

Chief Executive Officer

You may also like